Vext Science, Inc.
VEXT
CNSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -5.36% | -10.75% | -13.23% | -4.92% | 6.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.36% | -10.75% | -13.23% | -4.92% | 6.38% |
| Cost of Revenue | 48.75% | 9.85% | -26.06% | -42.47% | -27.29% |
| Gross Profit | -37.03% | -25.53% | -1.57% | 42.64% | 45.92% |
| SG&A Expenses | -2.72% | 13.67% | 45.26% | 63.93% | 42.67% |
| Depreciation & Amortization | 73.02% | 69.45% | 139.73% | 317.14% | 94.19% |
| Other Operating Expenses | -109.84% | -101.24% | -100.51% | -98.99% | -83.21% |
| Total Operating Expenses | 32.94% | 12.65% | -1.41% | -10.08% | -7.05% |
| Operating Income | -93.44% | -66.85% | -44.82% | 13.44% | 59.31% |
| Income Before Tax | -155.06% | -110.80% | -78.89% | -1.79% | 18.10% |
| Income Tax Expenses | -489.94% | -396.63% | -335.01% | -330.26% | 30.02% |
| Earnings from Continuing Operations | -11.43% | 16.96% | 43.25% | 118.97% | 13.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.43% | 16.96% | 43.25% | 118.97% | 13.64% |
| EBIT | -93.44% | -66.85% | -44.82% | 13.44% | 59.31% |
| EBITDA | -49.76% | -34.03% | -16.87% | 36.98% | 68.31% |
| EPS Basic | -5.70% | 21.60% | 49.76% | 112.81% | -6.08% |
| Normalized Basic EPS | -141.93% | -99.75% | -68.00% | -5.18% | -3.29% |
| EPS Diluted | 12.00% | 41.26% | 58.74% | 143.89% | -8.71% |
| Normalized Diluted EPS | -141.64% | -99.75% | -66.93% | -1.27% | 0.86% |
| Average Basic Shares Outstanding | -5.95% | -7.55% | -9.19% | -5.15% | 27.75% |
| Average Diluted Shares Outstanding | -6.44% | -8.96% | -11.93% | -8.26% | 22.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
